Longterm treatment with endothelin receptor antagonist bosentan and iloprost improves fingertip blood perfusion in systemic sclerosis

Cutolo M

•

•

Pizzorni C

altro

Sulli A

2014

journal article

Periodico

THE JOURNAL OF RHEUMATOLOGY

Abstract

To evaluate the longterm effects of endothelin-1 (ET-1) antagonism on peripheral blood perfusion (PBP) in patients with systemic sclerosis (SSc).

DOI

10.3899/jrheum.131284

WOS

WOS:000335514500011

Archivio

http://hdl.handle.net/11368/3003738

info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84899717942

Diritti

metadata only access

Soggetti